½ÃÀ庸°í¼­
»óǰÄÚµå
1618268

À¯Ã¼ °ü¸® ½Ã½ºÅÛ : ½ÃÀå ÀλçÀÌÆ®, °æÀï »óȲ, ½ÃÀå ¿¹Ãø(-2030³â)

Fluid Management Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DelveInsight | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 13.36%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº ±Þ¼º ½ÅÀå ÁúȯÀ» Æ÷ÇÔÇÑ ¸¸¼ºÁúȯÀÇ ³ôÀº ¹ßº´·ü, ºñ¸¸°ú °°Àº »ýȰ½À°üº´, ÁÖ¿ä ±â¾÷µéÀÇ Á¦Ç° °³¹ß Ȱµ¿ Áõ°¡, ´Ù¾çÇÑ À¯Ã¼ °ü¸® ½Ã½ºÅÛÀÇ °¡¿ë¼º µîÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

À¯Ã¼ °ü¸® ½Ã½ºÅÛ : ½ÃÀå ¿ªÇÐ

WHO°¡ Á¦°øÇÑ µ¥ÀÌÅÍ(2024³â)¿¡ µû¸£¸é, 2022³â¿¡´Â Àü ¼¼°è Àα¸ 8¸í Áß 1¸íÀÌ ºñ¸¸ÀÎ °ÍÀ¸·Î Ãß»êµË´Ï´Ù. ÀÌ ÀÚ·á¿¡ µû¸£¸é, 2022³â¿¡´Â Àü ¼¼°è ¾à 25¾ï ¸íÀÌ °úüÁßÀ̸ç, ±× Áß 8¾ï 9,000¸¸ ¸íÀÌ ºñ¸¸ÀÎ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ºñ¸¸°ú °ü·Ã ÇÕº´ÁõÀÇ À¯º´·üÀÌ Àü ¼¼°èÀûÀ¸·Î Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó, ÁßÁõ ºñ¸¸¿¡ ´ëÇÑ È¿°úÀûÀÎ Ä¡·á¹ýÀ¸·Î ºñ¸¸ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñ¸¸ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¼ö¼ú¿¡ »ç¿ëµÇ´Â À¯Ã¼ °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á÷°áµË´Ï´Ù.

International Society of NephrologyÀÇ µ¥ÀÌÅÍ(2021³â)¿¡ µû¸£¸é, ¿¬°£ ±Þ¼º½ÅºÎÀü ȯÀÚ ¼ö´Â Àü ¼¼°èÀûÀ¸·Î ¾à 1,330¸¸ °ÇÀ¸·Î Ãß»êµË´Ï´Ù. ¼ö¾× °ü¸® ½Ã½ºÅÛÀº Á¤È®ÇÑ ¼ö¾× ±ÕÇüÀ» º¸ÀåÇÏ¿© ±Þ¼º ½ÅºÎÀüÀ» °ü¸®ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, ü¾× °ú´Ù ¹× Ç÷¾×·® °¨¼Ò¿Í °°Àº ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â µ¥ Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº Ç÷¾×Åõ¼®À̳ª Áö¼ÓÀû ½Å´ëü¿ä¹ý°ú °°Àº ½Å´ëü¿ä¹ý¿¡ ÇʼöÀûÀÔ´Ï´Ù.

Á¦Ç°º°·Î´Â Åõ¼®±â ºÎ¹®ÀÌ 2023³â °¡Àå Å« ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇß½À´Ï´Ù. ÀÌ Á¦Ç° Ä«Å×°í¸®ÀÇ ºü¸¥ ¼ºÀåÀº ´ç´¢º´°ú °íÇ÷¾Ð°ú °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¸¸¼º ½ÅÀå Áúȯ(CKD)°ú ¸»±â ½ÅÀå ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

¶ÇÇÑ, ÈÞ´ë¿ë ¹× ÀçÅà Åõ¼® ½Ã½ºÅÛ µî Åõ¼® ±â¼úÀÇ ¹ßÀü°ú Á¶±â CKD °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó È®Ãæ°ú ½ÅÀå Ä¡·á¸¦ Áö¿øÇÏ´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¼¼°è À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ±ÔÁ¦ ȯ°æ, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢ ºÎ¹®º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ : ¼Ò°³

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ºÐ·ù
  • ½ÃÀå »óÁ¤

Á¦2Àå À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦3Àå °æÀï ±¸µµ

Á¦4Àå ±ÔÁ¦ ºÐ¼®

  • ¹Ì±¹
  • À¯·´
  • ÀϺ»
  • Áß±¹

Á¦5Àå À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀå : ÁÖ¿ä ¿äÀÎ ºÐ¼®

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼ºÁúȯ Áõ°¡
    • Á¦Ç° °³¹ß Ȱµ¿ Ȱ¹ßÈ­
    • ¿Ü°ú¼ö¼ú ºÎ´ã Áõ°¡
    • Æø³ÐÀº À¯Ã¼ °ü¸® ½Ã½ºÅÛÀÇ Á¦°ø
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
    • ´ëü Ä¡·á ¿É¼Ç ÀÌ¿ë °¡´É¼º
    • »óóÀÇ °³¹æ, ÁÖº¯ Á¶Á÷ÀÇ ¼Õ»ó µî À¯Ã¼ °ü¸® ½Ã½ºÅÛ°ú °ü·ÃµÈ ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • ÈÞ´ë¿ë °¡Á¤¿ë À¯Ã¼ °ü¸® ½Ã½ºÅÛ °³¹ß

Á¦6Àå À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀå : Porter's Five Forces ºÐ¼®

Á¦7Àå À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀå Æò°¡

  • Á¦Ç°º°
    • ½Ã½ºÅÛ
    • ¾×¼¼¼­¸®
  • ¿ëµµº°
    • ºñ´¢±â
    • ½ÉÀ庴
    • ¼ÒÈ­±â³»°ú
    • ±âŸ
  • Áö¿ªº°
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±âŸ Áö¿ª

Á¦8Àå À¯Ã¼ °ü¸® ½Ã½ºÅÛ ½ÃÀå : ±â¾÷¡¤Á¦Ç° ÇÁ·ÎÆÄÀÏ

  • NIPRO CORPORATION
  • B. Braun Melsungen AG
  • Stryker
  • Ackermann Instrumente GmbH
  • Medline Industries, LP.
  • Aesculap, Inc.
  • dialifegroup
  • Cardinal Health
  • JINSHAN Science & Technology
  • Acteon Group
  • CONMED Corporation
  • EMBITRON s.r.o., c.p.
  • EMS Urology
  • Infomed SA
  • EndoMed Systems GmbH
  • Erbe Elektromedizin GmbH
  • Meril Life Sciences Pvt. Ltd
  • Baxter
  • Hologic, Inc
  • Electronics Services Centre(ESC Medicams)

Á¦9Àå KOLÀÇ °ßÇØ

Á¦10Àå ÇÁ·ÎÁ§Æ® Á¢±Ù¹ý

Á¦11Àå DelveInsight ¼Ò°³

Á¦12Àå ¸éÃ¥»çÇס¤¹®ÀÇ

ksm 25.01.10

Fluid management system by Product [Systems (Dialysis Machine, Irrigation and Suction Systems, Fluid Warming Systems, Fluid Waste Management Systems, and Others) and Accessories (Bloodlines, Catheters, Transducers, Tubing Set, and Others)], Application (Urology, Cardiology, Gastroenterology, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases and rising product developmental activities globally

The fluid management system market is estimated to grow at a CAGR of 13.36% during the forecast period from 2024 to 2030. The fluid management system market is growing significantly due to the high incidence of chronic disorders including acute kidney disease, lifestyle disorders like obesity, rising product developmental activities by key players, availability of wide range of fluid management system among others that are expected to drive the market for fluid management system during the forecast period from 2024 to 2030.

Fluid Management System Market Dynamics:

According to the data provided by the World Health Organization (2024), in 2022 globally out of 8 people, 1 person was living with obesity. Furthermore, as per the same source in 2022, approximately 2.5 billion people were overweight and out of these 890 million people were living with obesity worldwide. As the prevalence of obesity and related comorbidities continues to rise globally, there is a growing demand for bariatric surgery as an effective treatment option for severe obesity. This increased demand for bariatric procedures directly translates to a higher demand for fluid management systems used in these surgeries.

As per data from the International Society of Nephrology 2021, each year, there are around 13.3 million cases of acute kidney injury globally and the increased burden is on emerging countries where the annual incidence is estimated to be 11.3 million. Fluid management systems are critical in managing acute kidney injury by ensuring precise fluid balance, a key factor in preventing complications like volume overload or hypovolemia. These systems are integral in renal replacement therapies) such as hemodialysis or continuous renal replacement therapy.

The increasing product launches, approvals, and other activities will also drive the market of fluid management systems. For instance, in January 2021, Hologic, Inc. launched a CE-marked Fluent fluid management system, to provide simpler and more effective fluid management during hysteroscopic procedures. The new system is designed to give clinicians more confidence by providing consistent intrauterine pressure and accurate fluid detection readings. Its advanced technology is designed to help maintain consistent intra-cavity pressure, and uterine distention and measure fluid readings within +/- 50 mL.

Therefore, the factors stated above collectively will drive the overall fluid management system market during the forecast period from 2024 to 2030.

However, the availability of alternative treatment options and complications associated with fluid management systems such as wound dehiscence or damage to surrounding tissues and others may limit their end-user base, thus acting as key constraints limiting the growth of the fluid management system.

Fluid Management System Market Segment Analysis:

Fluid management system by Product [Systems (Dialysis Machine, Irrigation and Suction Systems, Fluid Warming Systems, Fluid Waste Management Systems, and Others) and Accessories (Bloodlines, Catheters, Transducers, Tubing Set, and Others)], Application (Urology, Cardiology, Gastroenterology, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the fluid management system, the dialysis machine sub-category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category is due to the growing prevalence of chronic kidney disease (CKD) and end-stage renal disease, driven by factors like diabetes and hypertension.

Additionally, advancements in dialysis technology, such as portable and home-based systems, along with rising awareness of early CKD management, are boosting adoption. Increasing healthcare infrastructure and government initiatives supporting renal care further contribute to market growth.

New product approvals are also likely to upsurge the market for these. For instance, in September 2022, Terumo Corporation received regulatory approval from the National Medical Products Administration (NMPA) to manufacture and market a novel neutral peritoneal dialysis solution.

Therefore, owing to all the above-mentioned factors, the demand for the dialysis machine sub-category is expected to witness considerable growth eventually contributing to the overall growth of the fluid management system market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall fluid management system market:

Among all the regions, North America is expected to dominate the fluid management system market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This can be ascribed to the increasing surgical procedures, advancements in product development, significant contributions of key market players, and growing research and development activities in the region. The combination of these factors is expected to drive the continued expansion and innovation in the market for fluid management systems during the forecast period from 2024 to 2030.

According to the American Academy of Orthopaedic Surgeons (2024), in 2021 more than 100,000 shoulder replacement surgeries were performed annually in the U.S., encompassing total shoulder replacement, hemi arthroplasty, and reverse total shoulder replacement. As per the same source, it projects that by 2025, the number of shoulder replacement procedures in the U.S. could range between 174,000 and 350,000. They are utilized for irrigation and suction during the procedure, ensuring a clear surgical field by removing blood, debris, and bone fragments. Fluid management system enhances visibility, minimizes infection risk, and aids in precise implant placement. Additionally, these systems regulate intraoperative fluid balance, optimizing outcomes and reducing postoperative complications.

Rising product launches and commercialization agreements among key manufacturers and other companies are anticipated to boost the market. For instance, in December 2021, Kelyniam Global, a leader in the design and manufacture of custom cranial implants, announced that the United States Patent and Trademark Office issued the company an Issue Notification for a patent covering the company's Integrated Fixation Tabs, that was marketed as IFS Tabs or KwikTabs. The US patent covers the integration of fixation appendages into a cranial implant and their design.

Also, the presence of key market players in the region is significantly bolstering the market for fluid management systems. Major companies like B. Braun Melsungen AG, Stryker, and Baxter, have established strong footholds in the region, driving innovation and market growth. The extensive research and development activities, combined with a robust distribution network, enable these players to deliver high-quality, technologically advanced products to a wide end-user base.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North America region in the fluid management system market.

Fluid Management System Market key players:

Some of the key market players operating in the fluid management system market include NIPRO CORPORATION, B. Braun Melsungen AG, Stryker, Ackermann Instrumente GmbH, Medline Industries, LP., Aesculap, Inc., dialifegroup, Cardinal Health, JINSHAN Science & Technology, Acteon Group, CONMED Corporation, EMBITRON s.r.o., c.p., EMS Urology, Infomed SA, EndoMed Systems GmbH, Erbe Elektromedizin GmbH, Meril Life Sciences Pvt. Ltd, Baxter, Hologic, Inc, Electronics Services Centre (ESC Medicams), and others.

Recent Developmental Activities in the Fluid Management System Market:

  • In April 2022, Transit Scientific announced FDA 510(k) clearance of the company's XO cross-support catheter platform to include it in coronary use. The platform is indicated to guide and support a guidewire during access of the peripheral or coronary vasculature, allow for wire exchanges, and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.
  • In August 2022, the Bodyport cardiac scale was cleared by the US Food and Drug Administration for fluid management assessment. The Cardiac Scale solution allows patients with fluid management in various conditions such as heart failure and kidney disease to non-invasively assess cardiac function and fluid status in the same step taken for weight measurement.

Key Takeaways from the Fluid Management System Market Report Study

  • Market size analysis for current fluid management system market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the fluid management system market
  • Various opportunities available for the other competitors in the fluid management system market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current fluid management system market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for fluid management system market growth in the coming future?

Target audience who can be benefited from this Fluid Management System Market Report Study

  • Fluid management system product providers
  • Research organizations and consulting companies
  • Fluid management system-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in fluid management system
  • Various end-users who want to know more about the fluid management system market and the latest developments in the fluid management system market

Frequently Asked Questions for the Fluid Management System Market:

1. What are fluid management system?

  • The fluid management system is a technique for controlling bodily fluid that includes controlling a patient's fluid medical demand as well as fluid waste from the operating room. Fluid management systems offer functionalities such as warming and filtration, deficit monitoring, and irrigation, among others.

2. What is the market for fluid management system?

  • The fluid management system market is estimated to grow at a CAGR of 13.36% during the forecast period from 2024 to 2030.

3. What are the drivers for the fluid management system market?

  • The fluid management system market is growing significantly due to the high incidence of chronic disorders including acute kidney disease, lifestyle disorders like obesity, rising product developmental activities by key players, and availability of a wide range of fluid management systems among others that are expected to drive the market for fluid management system during the forecast period from 2024 to 2030.

4. Who are the key players operating in the fluid management system market?

  • Some of the key market players operating in the fluid management system market include NIPRO CORPORATION, B. Braun Melsungen AG, Stryker, Ackermann Instrumente GmbH, Medline Industries, LP., Aesculap, Inc., dialifegroup, Cardinal Health, JINSHAN Science & Technology, Acteon Group, CONMED Corporation, EMBITRON s.r.o., c.p., EMS Urology, Infomed SA, EndoMed Systems GmbH, Erbe Elektromedizin GmbH, Meril Life Sciences Pvt. Ltd, Baxter, Hologic, Inc, Electronics Services Centre (ESC Medicams), and others.

5. Which region has the highest share in the fluid management system market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the fluid management system market. This can be ascribed to the increasing surgical procedures, advancements in product development, significant contributions of key market players, and growing research and development activities in the region. The combination of these factors is expected to drive the continued expansion and innovation in the market for fluid management system during the forecast period from 2024 to 2030.

Table of Contents

1. Fluid Management System Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Fluid Management System Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Fluid Management System Market Key Factors Analysis

  • 5.1. Fluid Management System Market Drivers
    • 5.1.1. Increasing prevalence of chronic diseases
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Growing burden of surgical procedures
    • 5.1.4. Availability of a wide range of fluid management system
  • 5.2. Fluid Management System Market Restraints and Challenges
    • 5.2.1. Availability of alternative treatment options
    • 5.2.2. Complications associated with fluid management systems such as wound dehiscence or damage to surrounding tissues
  • 5.3. Fluid Management System Market Opportunities
    • 5.3.1. Development of portable home-based fluid management system

6. Fluid Management System Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Fluid Management System Market Assessment

  • 7.1. By Product
    • 7.1.1. Systems
      • 7.1.1.1. Dialysis Machines
      • 7.1.1.2. Irrigation and Suction Systems
      • 7.1.1.3. Fluid Warming Systems
      • 7.1.1.4. Fluid Waste Management Systems
      • 7.1.1.5. Others
    • 7.1.2. Accessories
      • 7.1.2.1. Bloodlines
      • 7.1.2.2. Catheters
      • 7.1.2.3. Transducers
      • 7.1.2.4. Tubing set
      • 7.1.2.5. Others
  • 7.2. By Application
    • 7.2.1. Urology
    • 7.2.2. Cardiology
    • 7.2.3. Gastroenterology
    • 7.2.4. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Fluid Management System Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Fluid Management System Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.3.3. India Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Fluid Management System Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Fluid Management System Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Fluid Management System Market Size in USD million (2021-2030)

8. Fluid Management System Market Company and Product Profiles

  • 8.1. NIPRO CORPORATION
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. B. Braun Melsungen AG
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Stryker
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Ackermann Instrumente GmbH
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Medline Industries, LP.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Aesculap, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. dialifegroup
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Cardinal Health
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. JINSHAN Science & Technology
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Acteon Group
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. CONMED Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. EMBITRON s.r.o., c.p.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. EMS Urology
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Infomed SA
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. EndoMed Systems GmbH
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Erbe Elektromedizin GmbH
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Meril Life Sciences Pvt. Ltd
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Baxter
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Hologic, Inc
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Electronics Services Centre (ESC Medicams)
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦